ZYBT
Zhengye Biotechnology Holding Limited
1.20$
-1.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
Zhengye Biotechnology Holding Limited (ZYBT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at 27 million CNY. Tick rows to compare them in a chart.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 25 | Q1 26 |
|---|---|---|
| 14 | 27 | |
| 6.9 | 13 | |
| 23 | 44 | |
| 0.4 | 0.7 | |
| -6.0 | -12 | |
| 0.0 | – | |
| -5.0 | -9.1 | |
| – | 5.9 | |
| 13 | 26 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.